ArticleScientific reports2016

Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk.

Mei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.